My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 192

    1.

    Nitrergic neurodegeneration in cerebral arteries of streptozotocin-induced diabetic rats: a new insight into diabetic stroke.

    Cellek S, Anderson PN, Foxwell NA.

    Diabetes. 2005 Jan;54(1):212-9.PMID: 15616031 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Two phases of nitrergic neuropathy in streptozotocin-induced diabetic rats.

    Cellek S, Foxwell NA, Moncada S.

    Diabetes. 2003 Sep;52(9):2353-62.PMID: 12941776 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Synergistic action of advanced glycation end products and endogenous nitric oxide leads to neuronal apoptosis in vitro: a new insight into selective nitrergic neuropathy in diabetes.

    Cellek S, Qu W, Schmidt AM, Moncada S.

    Diabetologia. 2004 Feb;47(2):331-9. Epub 2003 Dec 16.PMID: 14676945 [PubMed - indexed for MEDLINE]Related articles

    4.

    Point of NO return for nitrergic nerves in diabetes: a new insight into diabetic complications.

    Cellek S.

    Curr Pharm Des. 2004;10(29):3683-95. Review.PMID: 15579064 [PubMed - indexed for MEDLINE]Related articles

    5.

    Selective nitrergic neurodegeneration in diabetes mellitus - a nitric oxide-dependent phenomenon.

    Cellek S, Rodrigo J, Lobos E, Fernández P, Serrano J, Moncada S.

    Br J Pharmacol. 1999 Dec;128(8):1804-12.PMID: 10588937 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Role of nitrosative stress in early neuropathy and vascular dysfunction in streptozotocin-diabetic rats.

    Obrosova IG, Drel VR, Oltman CL, Mashtalir N, Tibrewala J, Groves JT, Yorek MA.

    Am J Physiol Endocrinol Metab. 2007 Dec;293(6):E1645-55. Epub 2007 Oct 2.PMID: 17911342 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Enalapril prevents impaired nitric oxide synthase-dependent dilatation of cerebral arterioles in diabetic rats.

    Trauernicht AK, Sun H, Patel KP, Mayhan WG.

    Stroke. 2003 Nov;34(11):2698-703. Epub 2003 Oct 16.PMID: 14563973 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Projections of nitric oxide synthase-containing fibers from the sphenopalatine ganglion to cerebral arteries in the rat.

    Minami Y, Kimura H, Aimi Y, Vincent SR.

    Neuroscience. 1994 Jun;60(3):745-59.PMID: 7523985 [PubMed - indexed for MEDLINE]Related articles

    9.

    Effect of diabetes and insulin treatment on nitric oxide synthase content in rat corpus cavernosum.

    Xu ZS, Fu Q, Zhao ST, Liu HN.

    Asian J Androl. 2001 Jun;3(2):139-42.PMID: 11404800 [PubMed - indexed for MEDLINE]Related articles

    10.

    Diabetes induces sex-dependent changes in neuronal nitric oxide synthase dimerization and function in the rat gastric antrum.

    Gangula PR, Maner WL, Micci MA, Garfield RE, Pasricha PJ.

    Am J Physiol Gastrointest Liver Physiol. 2007 Mar;292(3):G725-33.PMID: 17347455 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Macrovascular disease of coronaries and cerebral arteries in streptozotocin-induced diabetic rats. A controlled, comparative study.

    Mavrikakis ME, Sfikakis PP, Kontoyannis D, Horti M, Kittas C, Koutras DA, Raptis SA.

    Exp Clin Endocrinol Diabetes. 1998;106(1):35-40.PMID: 9516057 [PubMed - indexed for MEDLINE]Related articles

    12.

    Nitric oxide as a potential bridge between the metabolic and vascular hypotheses of diabetic neuropathy.

    Stevens MJ.

    Diabet Med. 1995 Apr;12(4):292-5. Review.PMID: 7600740 [PubMed - indexed for MEDLINE]Related articles

    13.

    Effect of aminoguanidine on the impaired nitric oxide-mediated neurotransmission in anococcygeus muscle from diabetic rats.

    Way KJ, Reid JJ.

    Neuropharmacology. 1994 Nov;33(11):1315-22.PMID: 7870288 [PubMed - indexed for MEDLINE]Related articles

    14.

    The calpain inhibitor, A-705253, corrects penile nitrergic nerve dysfunction in diabetic mice.

    Nangle MR, Cotter MA, Cameron NE.

    Eur J Pharmacol. 2006 May 24;538(1-3):148-53. Epub 2006 Apr 5.PMID: 16650403 [PubMed - indexed for MEDLINE]Related articles

    15.

    Insulin reversal of impaired nitrergic transmission in the anococcygeus muscle from diabetic rats.

    Way KJ, Reid JJ.

    Pharmacology. 1999 Sep;59(3):115-26.PMID: 10450066 [PubMed - indexed for MEDLINE]Related articles

    16.

    Carvedilol ameliorates endothelial dysfunction in streptozotocin-induced diabetic rats.

    Fu GS, Huang H, Chen F, Wang HP, Qian LB, Ke XY, Xia Q.

    Eur J Pharmacol. 2007 Jul 19;567(3):223-30. Epub 2007 Feb 27.PMID: 17559835 [PubMed - indexed for MEDLINE]Related articles

    17.

    Nitric oxide: from basic research on isolated blood vessels to clinical relevance in diabetes.

    Furchgott RF.

    An R Acad Nac Med (Madr). 1998;115(2):317-31. No abstract available. PMID: 9882827 [PubMed - indexed for MEDLINE]Related articles

    18.

    Diabetes causes an early reduction in autonomic ganglion blood flow in rats.

    Cameron NE, Cotter MA.

    J Diabetes Complications. 2001 Jul-Aug;15(4):198-202.PMID: 11457672 [PubMed - indexed for MEDLINE]Related articles

    19.

    Innervation and connexin isoform expression during diabetes-related bladder dysfunction: early structural vs. neuronal remodelling.

    Poladia DP, Schanbacher B, Wallace LJ, Bauer JA.

    Acta Diabetol. 2005 Oct;42(3):147-52.PMID: 16258738 [PubMed - indexed for MEDLINE]Related articles

    20.

    Treatment of streptozotocin-induced diabetic rats with AVE7688, a vasopeptidase inhibitor: effect on vascular and neural disease.

    Davidson EP, Kleinschmidt TL, Oltman CL, Lund DD, Yorek MA.

    Diabetes. 2007 Feb;56(2):355-62.PMID: 17259379 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity